| MolName | (2Z)-2-[3-(4-bromophenyl)-5-[(3,4-dichlorophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyano-N-(furan-2-ylmethyl)acetamide |
| MolecularFormula | C24H16N3O3BrCl2S |
| Smiles | N#C/C(/C(NCc1ccco1)=O)=C(\N1c(cc2)ccc2Br)/SC(Cc(cc2)cc(Cl)c2Cl)C1=O |
| InChI | InChI=1S/C24H16BrCl2N3O3S/c25-15-4-6-16(7-5-15)30-23(32)21(11-14-3-8-19(26)20(27)10-14)34-24(30)18(12-28)22(31)29-13-17-2-1-9-33-17/h1-10,21H,11,13H2,(H,29,31)/t21-/m1/s1 |
| InChIK | RBBOPARJSZWUTF-OAQYLSRUSA-N |
| TotalMolweight | 577.285 |
| Molweight | 577.285 |
| MonoisotopicMass | 574.947277 |
| CLogP | 5.5504 |
| CLogS | -7.618 |
| H Acceptors | 6 |
| H Donors | 1 |
| TotalSurfaceArea | 377.84 |
| Relative PSA | 0.22827 |
| PolarSurfaceArea | 111.64 |
| Druglikeness | -0.18443 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | polar activated DB; twice activated DB |
| Shape Index | 0.47059 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 6 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 4 |
| Symmetricatoms | 2 |
| Amides | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (2Z)-2-[3-(4-bromophenyl)-5-[(3,4-dichlorophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyano-N-(furan-2-ylmethyl)acetamide | 2 - (2Z)-2-[3-(4-bromophenyl)-5-[(3,4-dichlorophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyano-N-(furan-2-ylmethyl)acetamide